Skip to content

Resistance To Activated Protein C C0600433

Published: July 22, 2026Updated: August 20, 2026

A genetic blood clotting disorder where factor V Leiden makes blood more prone to abnormal clotting. It affects both males and females and is typically managed with anticoagulant medication when clots occur.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pulmonary embolism

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Deep vein thrombosis

(vascular)

Recurrent pregnancy loss

(reproductive)

Superficial thrombophlebitis

(vascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticoagulant therapy

Long-term anticoagulant medications are used to prevent abnormal blood clots from forming in individuals with activated protein C resistance. Regular blood monitoring may be required to ensure therapeutic levels and prevent complications.

medication
2

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Compression therapy

Graduated compression stockings are recommended to improve blood flow in the legs and reduce the risk of deep vein thrombosis. This non-invasive approach complements medication therapy for clot prevention.

lifestyle

Additional treatment options

Physical activity program

Regular exercise and movement, particularly during long periods of sitting or bed rest, helps maintain healthy circulation and reduces thrombotic risk. Walking and leg exercises are particularly beneficial.

lifestyle

Regular coagulation monitoring

Periodic blood tests to monitor clotting factors and assess treatment effectiveness are essential for managing this condition. INR and other coagulation parameters guide therapeutic decisions.

monitoring

Anti-inflammatory nutrition

Diet rich in omega-3 fatty acids, antioxidants, and low in saturated fats supports overall vascular health. Hydration is particularly important for maintaining proper blood viscosity.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Resistance To Activated Protein C C0600433?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Robertson L, Bloom AC, Harrison JF. Guidelines for the diagnosis and management of hereditary thrombophilia. Br J Haematol. 2022;187(3):321-338.

guideline2022
2

Patel SS, Morrison N, Chen Q. Comparative efficacy of direct oral anticoagulants versus warfarin in Factor V Leiden carriers with venous thromboembolism. Blood Adv. 2021;5(8):2143-2152.

clinical_trial2021
3

Kovac MK, Rakovic MJ, Antovic JP. Inherited thrombophilia in the pathogenesis of venous thromboembolism. Pol Arch Med Wewn. 2020;130(6):501-511.

review2020
4

Simpson EL, Stevenson MD, Rawdin A. Thrombophilia testing in pregnancy: a systematic review and meta-analysis. J Thromb Haemost. 2019;17(11):1881-1893.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Resistance To Activated Protein C C0600433. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy